secwatch.observer — SEC 8-K summary
======================================

Issuer:     TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK:        0001630627
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0000950170-23-004148
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two co-founders to retire from Treace Medical board; director reclassified
--------------------------------------------------------------------------

- F. Barry Bays and Thomas Timbie will retire from the Board at the 2023 annual meeting and not stand for re-election.
- Both have served since the company's founding in June 2014; retirements not due to any disagreement.
- Director Jane E. Kiernan reclassified as Class II director effective immediately before the 2023 annual meeting.
- Kiernan will stand for election as a Class II director at the 2023 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630627/000095017023004148/0000950170-23-004148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630627/000095017023004148/tmci-20230216.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-004148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer